COMMUNIQUÉS West-GlobeNewswire

Communiqué de presse : Mise en ligne du document "Q3 2025 Aide mémoire"
24/09/2025
Mise en ligne du document «Q3 2025 Aide mémoire » Paris, France, le 24 septembre 2025 . Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Q3 2025 Aide [...]
Press release: Availability of the Q3 2025 Aide mémoire
24/09/2025
Availability of the Q3 2025 Aide mémoire Paris, France – September 24, 2025 . Sanofi announced today that its Q3 2025 Aide mémoire is available on the "Investors" page of the company's website: Third quarter 2025 ( [...]
Dimora PHMB Skin and Wound Cleanser - Gentle for Kids, Trusted by Parents
24/09/2025
Dimora PHMB Skin and Wound Cleanser: Gentle for Kids, Trusted by Parents SAN FRANCISCO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Dimora Medical is proud to introduce its newest innovation, the Dimora PHMB Skin and Wound [...]
Communiqué de presse : Sanofi engage 625 millions de dollars supplémentaires dans Sanofi Ventures, afin d’accélérer ses investissements dans les biotechnologies et l’innovation en matière de santé numérique
24/09/2025
Sanofi engage 625 millions de dollars supplémentaires dans Sanofi Ventures, afin d’accélérer ses investissements dans les biotechnologies et l’innovation en matière de santé numérique Le fonds restera axé sur les [...]
Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
24/09/2025
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation The fund will remain focused on Sanofi's key areas of immunology, rare diseases, neurology, [...]
Synendos Therapeutics Reports Positive and Highly Promising Topline Results from Phase 1 Trials, Paving the Way for Phase 2 in Mental Health
24/09/2025
The studies established the lead asset to be well tolerated in healthy volunteers at all doses with a good safety profile SYT-510 demonstrated penetration in the central nervous system and a pharmacodynamic effect on [...]
Correction d’une erreur matérielle relative au nombre total de droits de vote et d’actions composant le capital
24/09/2025
Correction d’une erreur matérielle relative au nombre total de droits de vote et d’actions composant le capital Mise au Point Face aux Accusations Infondées Nantes, le 24 septembre 2025 à 8 h 00 CET –OSE [...]
Correction of a Material Error Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital
24/09/2025
Correction of a Material Error Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital Clarification in Response to Unfounded Accusations NANTES, France – September 24, 2025, 8:00 a.m. CET [...]
Roche presents new data for OCREVUS and fenebrutinib across broad patient populations at ECTRIMS 2025
24/09/2025
OCREVUS subcutaneous maintains consistent benefit-risk profile after two years New late-breaking data confirms OCREVUS significantly reduces disability progression in adults with advanced PPMS One-year data reinforce [...]
New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies
24/09/2025
ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after breakthrough disease* [...]
Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer
24/09/2025
TOKYO and GUANGZHOU, China, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd. (Riken Genesis) and Burning Rock Biotech Limited (NASDAQ: BNR, “Burning Rock”) today announced that the OncoGuide™ OncoScreen™ Plus [...]
CARBIOS présente ses résultats semestriels 2025 et confirme son objectif de construction d’usine de biorecyclage du PET avec un calendrier décalé
24/09/2025
CARBIOS a réduit ses dépenses opérationnelles et dispose d’une solide position de trésorerie de 72 millions d’euros au 30 juin 2025, lui permettant de disposer d'un horizon de trésorerie de plus de 12 mois. Le projet de [...]
CARBIOS presents its 2025 half-year results and confirms its objective to build a PET biorecycling plant, with a revised timeline.
24/09/2025
CARBIOS has reduced its operating expenses and has a strong cash position of €72 million as of June 30, 2025, providing a cash horizon of more than 12 months The Longlaville plant construction project is now supported [...]
Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients
24/09/2025
WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with [...]
Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
24/09/2025
WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics”, “Monopar”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative [...]
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting
24/09/2025
WALTHAM, Mass. and DUBLIN, Ireland, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc, (Nasdaq: MURA) (“ Mural ”), a clinical-stage immuno-oncology company, today announces for the purposes of the Irish Takeover [...]
Elevé Cosmetic Surgery Officially Opens in Coral Gables, Accepting a Limited Number of Patients Seeking a Boutique Surgical Experience
24/09/2025
MIAMI, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Elevé Cosmetic Surgery, a new boutique practice in Coral Gables, today announced that it is officially open and accepting a limited number of new patients for facial and [...]
PhenQ Australia Over the Counter | Fast Acting Fat Burner and Appetite Suppressant Australian Launch OTC by PhenQ
23/09/2025
New York City, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Leading natural weight loss pill brand PhenQ today announced the Australian over‑the‑counter launch of its fast‑acting fat burner and appetite suppressant, giving [...]
Ron Schaefer Named President and CEO of Emerald Communities, Emerald Heights, and Heron’s Key
23/09/2025
REDMOND, Wash., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Emerald Communities is proud to announce the appointment of Ron Schaefer as the new President and Chief Executive Officer of Emerald Communities, Emerald Heights, and [...]

Pages